GLP-1RA ever-users (33 386 individuals [6.1%]) were on average younger (t14 314 = 48.1) with a greater proportion of obesity (χ23 = 6433) than basal insulin ever-users (106 849 individuals [19.7%]). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.